US EditionPublished • loading... • Updated
ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering - PressReach
Summary by pressreach.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering - PressReach
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ SASKATOON, SK, March 20, 2026 /CNW/ – ZYUS Life Sciences Corporation (the “Company“) (TSXV: ZYUS), a clinical stage life sciences company focused on the development and commercialization of novel non-opioid pharmaceutical drug candidates for pain management, is pleased to announce that it has now completed the first tranche (the “First Tranche“) of its non…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
